Trial intelligence / Profile preview

Radiation Dosimetry of [18F]PBR111 in Healthy Volunteers

NCT06398392Phase 1Completed

Start
Jun 2024
Primary completion
Jul 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of [18F]PBR111. Primary endpoint: Measurement of radiation dosimetry and biodistribution of [18F]PBR111 at 6 months. Started Jun 2024; status: completed.

02

Drugs

[18F]PBR111

Beyond the preview

Go deeper on NCT06398392.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06398392.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call